Biofrontera settles patent dispute with Dusa over skin treatment
30-11-2021
Pfizer to settle Xeljanz suit with Teva
09-09-2021
Pfizer sues India generic drugmaker over cancer drug
14-01-2021
04-07-2014
Courtesy of Aurobindo Pharma
Pfizer has launched a lawsuit against Aurobindo Pharma accusing the Indian pharmaceutical company of infringing patents related to an antibiotic used to treat skin infections.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Aurobindo, Pfizer, ANDA, FDA, Tygacil